BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dron JS, Wang J, McIntyre AD, Iacocca MA, Robinson JF, Ban MR, Cao H, Hegele RA. Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias. BMC Med Genomics 2020;13:23. [PMID: 32041611 DOI: 10.1186/s12920-020-0669-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Lazarte J, Berberich AJ, Wang J, Hegele RA. A cautionary tale: Is this APOB whole-gene duplication actually pathogenic? Journal of Clinical Lipidology 2020;14:631-5. [DOI: 10.1016/j.jacl.2020.06.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Lazarte J, Hegele RA. Can genetic testing help in the management of dyslipidaemias? Current Opinion in Lipidology 2020;31:187-93. [DOI: 10.1097/mol.0000000000000690] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Brown EE, Sturm AC, Cuchel M, Braun LT, Duell PB, Underberg JA, Jacobson TA, Hegele RA. Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association. Journal of Clinical Lipidology 2020;14:398-413. [DOI: 10.1016/j.jacl.2020.04.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
4 Lin H, Fang Y, Han L, Chen J, Lou J, Yu J. Case Report: Identification of a Novel Homozygous Mutation in GPD1 Gene of a Chinese Child With Transient Infantile Hypertriglyceridemia. Front Genet 2021;12:726116. [PMID: 34484308 DOI: 10.3389/fgene.2021.726116] [Reference Citation Analysis]
5 Lazarte J, Hegele RA. Editorial comment: hazards of interpreting genetic reports. Curr Opin Lipidol 2021;32:81-2. [PMID: 33606402 DOI: 10.1097/MOL.0000000000000738] [Reference Citation Analysis]
6 Goldberg IJ, Ibrahim N, Bredefeld C, Foo S, Lim V, Gutman D, Huggins LA, Hegele RA. Ketogenic diets, not for everyone. J Clin Lipidol 2021;15:61-7. [PMID: 33191194 DOI: 10.1016/j.jacl.2020.10.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
7 Awan ZA, Rashidi OM, Al-Shehri BA, Jamil K, Elango R, Al-Aama JY, Hegele RA, Banaganapalli B, Shaik NA. Saudi Familial Hypercholesterolemia Patients With Rare LDLR Stop Gain Variant Showed Variable Clinical Phenotype and Resistance to Multiple Drug Regimen. Front Med (Lausanne) 2021;8:694668. [PMID: 34249980 DOI: 10.3389/fmed.2021.694668] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hegele RA, Dron JS. 2019 George Lyman Duff Memorial Lecture: Three Decades of Examining DNA in Patients With Dyslipidemia. ATVB 2020;40:1970-81. [DOI: 10.1161/atvbaha.120.313065] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Gill PK, Dron JS, Berberich AJ, Wang J, McIntyre AD, Cao H, Hegele RA. Combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia. J Clin Lipidol 2021;15:79-87. [PMID: 33303402 DOI: 10.1016/j.jacl.2020.11.006] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wand H, Knowles JW, Clarke SL. The need for polygenic score reporting standards in evidence-based practice: lipid genetics use case. Curr Opin Lipidol 2021;32:89-95. [PMID: 33538426 DOI: 10.1097/MOL.0000000000000733] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Dron JS, Hegele RA. Genetics of Hypertriglyceridemia. Front Endocrinol (Lausanne) 2020;11:455. [PMID: 32793115 DOI: 10.3389/fendo.2020.00455] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
12 Medeiros AM, Bourbon M. Polygenic contribution for familial hypercholesterolemia (FH). Curr Opin Lipidol 2021;32:392-5. [PMID: 34751168 DOI: 10.1097/MOL.0000000000000787] [Reference Citation Analysis]
13 Zuurbier LC, Defesche JC, Wiegman A. Successful Genetic Screening and Creating Awareness of Familial Hypercholesterolemia and Other Heritable Dyslipidemias in the Netherlands. Genes (Basel) 2021;12:1168. [PMID: 34440342 DOI: 10.3390/genes12081168] [Reference Citation Analysis]
14 Lazarte J, Hegele RA. DNA sequencing in familial hypercholesterolaemia: the next generation. Eur J Prev Cardiol 2021;28:873-4. [PMID: 33623969 DOI: 10.1093/eurjpc/zwaa044] [Reference Citation Analysis]
15 Lazarte J, Hegele RA. Volanesorsen for treatment of familial chylomicronemia syndrome. Expert Rev Cardiovasc Ther 2021;19:685-93. [PMID: 34261380 DOI: 10.1080/14779072.2021.1955348] [Reference Citation Analysis]
16 Reeskamp LF, Tromp TR, Defesche JC, Grefhorst A, Stroes ESG, Hovingh GK, Zuurbier L. Next-generation sequencing to confirm clinical familial hypercholesterolemia. Eur J Prev Cardiol 2021;28:875-83. [PMID: 34298557 DOI: 10.1093/eurjpc/zwaa451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Mohebi R, Chen Q, Hegele RA, Rosenson RS. Failure of cosegregation between a rare STAP1 missense variant and hypercholesterolemia. J Clin Lipidol 2020;14:636-8. [PMID: 32828708 DOI: 10.1016/j.jacl.2020.07.010] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Gill PK, Dron JS, Hegele RA. Genetics of hypertriglyceridemia and atherosclerosis. Curr Opin Cardiol 2021;36:264-71. [PMID: 33818545 DOI: 10.1097/HCO.0000000000000839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Gill PK, Dron JS, Dilliott AA, McIntyre AD, Cao H, Wang J, Movsesyan IG, Malloy MJ, Pullinger CR, Kane JP, Hegele RA. Ancestry-specific profiles of genetic determinants of severe hypertriglyceridemia. J Clin Lipidol 2021;15:88-96. [PMID: 33303403 DOI: 10.1016/j.jacl.2020.11.007] [Reference Citation Analysis]
20 Paquette M, Bernard S, Cariou B, Hegele RA, Genest J, Trinder M, Brunham LR, Béliard S, Baass A. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia. ATVB 2021;41:2632-40. [DOI: 10.1161/atvbaha.121.316106] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Gouni-Berthold I, Alexander VJ, Yang Q, Hurh E, Steinhagen-Thiessen E, Moriarty PM, Hughes SG, Gaudet D, Hegele RA, O'Dea LSL, Stroes ESG, Tsimikas S, Witztum JL; COMPASS study group. Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol 2021;9:264-75. [PMID: 33798466 DOI: 10.1016/S2213-8587(21)00046-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
22 Vlasschaert C, McIntyre AD, Thomson LA, Kennedy BA, Ratko S, Prasad C, Hegele RA. Abetalipoproteinemia Due to a Novel Splicing Variant in MTTP in 3 Siblings. J Investig Med High Impact Case Rep 2021;9:23247096211022484. [PMID: 34078172 DOI: 10.1177/23247096211022484] [Reference Citation Analysis]
23 Reeskamp LF, Tromp TR, Defesche JC, Grefhorst A, Stroes ES, Hovingh GK, Zuurbier L. Next-generation sequencing to confirm clinical familial hypercholesterolemia. Eur J Prev Cardiolog. [DOI: 10.1177/2047487320942996] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]